Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
PBL 13 Dust and Diesel Rick Allen Clinical features of restrictive lung disease Restrictive vs obstructive Chronic, diffuse non-infective lung diseases are based on their effect on pulmonary function tests; Obstructive = ↓ airflow due to ↑ resistance Restrictive = ↓ total lung capacity due to ↓ expansion of lung parenchyma. Expiratory flow is either normal or proportionately reduced. Types of restrictive disease Chest wall disorders: Neuromuscular diseases – poliomyelitis, Severe obesity, Pleural disease, kyphoscoliosis Chronic diffuse interstitial and infiltrative diseases: - Characterised by inflam. and fibrosis of the pulmonary CT, usually the most peripheral and delicate interstitium in the alveolar walls. CF: dyspnoea, tachypnea, end-inspiratory crackles, eventual cyanosis (without wheezing or evidence of obstruction) Physiologic features: ↓ CO diffusion capacity, ↓lung volume, ↓ compliance Complications: severe scarring and destruction (honey-comb lung), pulmonary HTNcor pulmonaleRHF Fibrosing diseases Idiopathic pulmonary fibrosis (IPF) – histologic fibrosis pattern is called usual interstitial pneumonia (UIP), needed for Dx. Pathogenesis – repeated epithelial activation/injury inflammatory response, ↑↑↑fibroblastic/myofibroblastic proliferation (fibroblastic foci – characteristic) TGF-β1 ↑ fibrogenesis/collagen deposition, inhibits caveolin-1 (inhibitor of collagen/ECM deposition), causes epithelial cell apoptosis. Morphology – gross: fibrosis mainly in lower lobe, subpleural and along interlobular septa. Dense fibrosis alveolar structure destruction honeycomb fibrosis Clinical course: insidious onset ↑ dyspnea on exertion and dry cough. 4070 y.o. Ltae stage = clubbing, hypoxemia, cyanosis. Mean survival <3 years. Tx. transplant Nonspecific interstitial pneumonia (NSIP) – better Px. Than UIP. Unknown path. Morphology – cellular pattern = mild/mod chronic inflam, lymphocytes, patchy/diffuse. Fibrosis = diffuse/patchy interstitial fibrosis unlike UIP Clinical course – dyspnea and cough lasting several months. 46-55 y.o. Cryptogenic organising pneumonia – PBL 13 Dust and Diesel Rick Allen Morphology – subpleural/peribronchial patchy airspace consolidation: fibroblasts and organising CT within alveolar ducts, alveoli and bronchioles (Masson bodies). Architecture unaffected. Clinical course – dyspnea and cough. Can recover spontaneously. Tx w. steroids for 6 months CT diseases – rheumatoid arthritis, SLE, systemic sclerosis (scleroderma) Pneumoconiosis Lung disease resulting from inhaled airborne agents and occupational hazards and air pollution. Pathogenesis – Development depends on 1. The amount of agent retained in lung and airways (dependant on concentration, duration and the effectiveness of clearance mechanisms)(silicosis, asbestosis) 2. Size, shape and aerodynamic properties of particle (buoyancy) 3. Particle solubility and physiochemical reactivity 4. Compounding effects of other irritants (smoking) -1-5µm diameter particles are the most dangerous as they can reach alveoli. - interalveolar macrophages are ↑ in number to combat excessive dust levels but can be overburdened. -larger particles can persist in lung parenchyma for years and resist dissolution fibrosing collagenous pneumoconiosis (silicosis) -smaller particles can enter lymphatics and blood systemic response or autoimmunity. Eg. Coal workers pneumoconiosis: Usually benign. carbon progressive massive fibrosis (PMF – very nasty) Silicosis: Slow progression, nodular, fibrosing. Inhalation of silica (silicon dioxide) interact w. epithelium cells and macrophages activation and release of IL-1, TNF, O2 free radicals, and fibrogenesis promoters lung collagen accumulation (nodules in upper lung hard collagenous scars. Can cavitate. Associated with ↑ risk of developing TB) Asbestosis: as above, with inflammation. Cannot digest/remove. Fibrosis begins at resp bronchioles then includes alveoli enlarged airspace w. thick fibrous walls. Lower lobes, subpleural. Oncogenic effects due to free radicals released and toxic chemicals absorbed/retained by fibre (develop distally) lung carcinoma and mesothelioma (pleural/peritoneal). Pleural plaques, fibrosis and effusions may occur. Drug induced – cytotoxic chemo drugs directly damage tissue, causing macrophage presence and fibrosis. Radiation/radiotherapy fibrosis. PBL 13 Dust and Diesel Rick Allen Granulomatous diseases Sarcoidosis – systemic disease, non-caseating granulomas of unknown cause bilateral hilar lymphadenopathy and lung involvement. Blamed on dodgy immune system, genetics and perhaps environmental exposure. Has langhans cells and looks a lot like TB, but no caseating necrosis! Hypersensitivity pneumonitis – inhalation of antigens immune over-reactiveness firbrosis of bronchioles. Interstital pneomonitis, non-caseating granulomas, interstitial fibrosishoneycombingobliterative bronchiolitis Pulmonary eosinophilia -a variety of scenarios, some of unknown origin, resulting in an increase in eosinophils (and sometimes lymphocytes, with the stray giant cell) within the septa of the lung, and at times in the alveola spaces. CF as per usual, but can also get high fever and night sweats. Smoking related interstitial diseases Desquamative interstitial pneumonia – smokers macrophages evident within alveoli airspaces (↑ cytoplasm, a dusty brown). Alveoli septa are thickened with lymphocytes, plasma cells and eosinophils, and are lined with cuboidal pneumocytes. Tx. – steroids and stop smoking. Respiratory bronchiolitis-associated interstitial lung disease – smoker macrophages at resp. bronchioles, alveolar ducts and peribronchioler spaces. Pulmonary alveolar proteinosis (PAP) -accumulation of acellular surfactant in the intra-alveolar and bronchiolar spaces. -Acquired: autoimmune Ab against GM-CSF impaired surfactant clearance by alveolar macrophages. -Congenital: mutations in surfactant protein genes accumulation in air space. -homogeneous granular precipitate within alveoli foci/confluent consolidation with minimal inflammatory reaction. ↑size and wt. of lung. Can get abnormalities in type II pneumocytes. -CF: dyspnoea of insidious onset, cough with gelatinous containing spuptum, febrile illnesses, cyanosis, OR benign and resolution. Tx. – congenital = transplant. Acquired = GM-CSF therapy and whole lung lavage.